Eurostars   Report issue

For profit Phase 2
Founded: Brussels Belgium (2014)

Organization Overview

First Clinical Trial
2014
NCT02157922
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Eurostars

Active Ingredients

Drugs in Phase 2 Trials (2)

clenbuterol (1 trial)

sodium alginate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cystic Fibrosis (Phase 2)

Fibrosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2